441 related articles for article (PubMed ID: 24527451)
1. Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.
Ayton S; Lei P
Biomed Res Int; 2014; 2014():581256. PubMed ID: 24527451
[TBL] [Abstract][Full Text] [Related]
2. Iron accumulation in Parkinson's disease.
Mochizuki H; Yasuda T
J Neural Transm (Vienna); 2012 Dec; 119(12):1511-4. PubMed ID: 23070727
[TBL] [Abstract][Full Text] [Related]
3. Low plasma serotonin linked to higher nigral iron in Parkinson's disease.
Jellen LC; Lewis MM; Du G; Wang X; Galvis MLE; Krzyzanowski S; Capan CD; Snyder AM; Connor JR; Kong L; Mailman RB; Brundin P; Brundin L; Huang X
Sci Rep; 2021 Dec; 11(1):24384. PubMed ID: 34934078
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and iron.
Mochizuki H; Choong CJ; Baba K
J Neural Transm (Vienna); 2020 Feb; 127(2):181-187. PubMed ID: 32025811
[TBL] [Abstract][Full Text] [Related]
5. Controversies about iron in parkinsonian and control substantia nigra.
Gałazka-Friedman J; Friedman A
Acta Neurobiol Exp (Wars); 1997; 57(3):217-25. PubMed ID: 9407708
[TBL] [Abstract][Full Text] [Related]
6. Association of freezing of gait with nigral iron accumulation in patients with Parkinson's disease.
Naduthota RM; Honnedevasthana AA; Lenka A; Saini J; Geethanath S; Bharath RD; Christopher R; Yadav R; Gupta AK; Pal PK
J Neurol Sci; 2017 Nov; 382():61-65. PubMed ID: 29111022
[TBL] [Abstract][Full Text] [Related]
7. Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique.
Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Wojcik S; Falkenberg G; Manka A; Lankosz M
J Biol Inorg Chem; 2007 Feb; 12(2):204-11. PubMed ID: 17120075
[TBL] [Abstract][Full Text] [Related]
8. XANES spectroscopy of a single neuron from a patient with Parkinson's disease.
Yoshida S; Ektessabi A; Fujisawa S
J Synchrotron Radiat; 2001 Mar; 8(Pt 2):998-1000. PubMed ID: 11513007
[TBL] [Abstract][Full Text] [Related]
9. Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.
Kaur D; Rajagopalan S; Andersen JK
Brain Res; 2009 Nov; 1297():17-22. PubMed ID: 19699718
[TBL] [Abstract][Full Text] [Related]
10. Iron histochemistry of the substantia nigra in Parkinson's disease.
Morris CM; Edwardson JA
Neurodegeneration; 1994 Dec; 3(4):277-82. PubMed ID: 7842298
[TBL] [Abstract][Full Text] [Related]
11. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.
Jin L; Wang J; Jin H; Fei G; Zhang Y; Chen W; Zhao L; Zhao N; Sun X; Zeng M; Zhong C
Eur J Neurol; 2012 Jul; 19(7):969-76. PubMed ID: 22288465
[TBL] [Abstract][Full Text] [Related]
12. Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.
Friedrich I; Reimann K; Jankuhn S; Kirilina E; Stieler J; Sonntag M; Meijer J; Weiskopf N; Reinert T; Arendt T; Morawski M
Acta Neuropathol Commun; 2021 Mar; 9(1):47. PubMed ID: 33752749
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
[TBL] [Abstract][Full Text] [Related]
14. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
15. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
Good PF; Olanow CW; Perl DP
Brain Res; 1992 Oct; 593(2):343-6. PubMed ID: 1450944
[TBL] [Abstract][Full Text] [Related]
16. Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.
Gröger A; Berg D
J Neural Transm (Vienna); 2012 Dec; 119(12):1523-8. PubMed ID: 22875636
[TBL] [Abstract][Full Text] [Related]
17. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
Gründemann J; Schlaudraff F; Haeckel O; Liss B
Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041
[TBL] [Abstract][Full Text] [Related]
18. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
Oakley AE; Collingwood JF; Dobson J; Love G; Perrott HR; Edwardson JA; Elstner M; Morris CM
Neurology; 2007 May; 68(21):1820-5. PubMed ID: 17515544
[TBL] [Abstract][Full Text] [Related]
19. The history of the research of iron in parkinsonian substantia nigra.
Friedman A; Galazka-Friedman J
J Neural Transm (Vienna); 2012 Dec; 119(12):1507-10. PubMed ID: 22941506
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiology of the brain stem in Parkinson's disease.
Bove C; Travagli RA
J Neurophysiol; 2019 May; 121(5):1856-1864. PubMed ID: 30917059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
